Home

Sujal Shah, CEO: CymaBay Therapeutics CBAY Sell · Filed 23/12/11

Trade details

Type
Insider sale
Amount
$18,520.9
Shares · price
890 sh · $20.81 a share
Held after
171,301 sh
Trade date
23/12/11
Filed
23/12/11
Days to filing
0 days

Sold 0.5% of holdings

Share of holding sold
0.5%

CymaBay Therapeutics trades, last 26 weeks

What else happened in CymaBay Therapeutics around then

Filed or reported within 30 days of the trade day · 23/11/11~24/01/10

Sujal Shah's recent trades

  • Sujal Shah

    Sell10b5-1 planCymaBay Therapeutics

    $1.3M

    Filed 23/12/11

  • Sujal Shah

    Sell10b5-1 planCymaBay Therapeutics

    $699.3K

    Filed 23/11/14

  • Sujal Shah

    Sell10b5-1 planCymaBay Therapeutics

    $331.4K

    Filed 23/11/14

  • Sujal Shah

    Sell10b5-1 planCymaBay Therapeutics

    $921K

    Filed 23/10/10

Sujal Shah, CEO — sold $18.5K of CymaBay Therapeutics CBAY · 0.5% of holdings · 10b5-1 plan | Whalegun